AVIR Competitors & Alternatives
Compare Atea Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
AVIR
Main Stock$4.21
Tradestie Score
55
Market Cap
$228.55M
Revenue Growth
3.0%
Analyst Upside
+101.9%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$13.36
|
$371.64M | - | 50 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$10.24
|
$357.51M | - | 31 | Compare |
|
DMAC
DiaMedica Therapeutics Inc. Common Stock
|
$9.33
|
$354.59M | - | 48 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$10.19
|
$354.45M | - | 43 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$42.46
|
$353.70M | - | 35 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$3.97
|
$332.96M | - | 49 | Compare |
|
REPL
Replimune Group, Inc.
|
$21.98
|
$328.62M | - | 28 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$7.81
|
$307.12M | - | 36 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.39
|
$304.12M | - | 51 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$15.87
|
$297.23M | - | 30 | Compare |
More AVIR Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2834)
223 stocks in this industry